AR and prostate cancer: As discussed above, Pirh2 was shown to regulate the AR activity in prostate cancer cells both directly by recruiting the AR transcription factor to the ARE sequence located in the promoter region of the PSA-coding gene and, indirectly, by downregulating the chromatin repressor, histone deacetylase HDAC1 [167].